ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 673267 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 673267; 2) Community: the network communities that were significantly associated with the response to NSC 673267; 3) Molecule: the relationships between components within communities and NSC 673267; 4) MDR: the compounds that were significantly associated with the NSC 673267.

NSC Compound Enrichment Correlation
NSC 269720 Androstan-17-one, 3-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (3.alpha.,5.alpha.)- 0.0385613993886001 0.094886894
NSC 269760 B8 0.0385613993886001 -0.28310694
NSC 281818 Ethanol, 2,2'-[[3-methyl-4-[[[4-[2-(4-propoxyphenyl]-4-thiazolyl]phenyl]imino]methyl]phenyl]imino]bis-, dimethanesulfonate (ester) 0.0385613993886001 0.15640648
NSC 301457 Cycloalkannin 0.0385613993886001 -0.046290569
NSC 303861 L-Cysteine analog 0.0385613993886001 -0.20433748
NSC 328477 3'-Chloro-3-nitro-o-salicylotoluidide 0.0385613993886001 -0.2392039
NSC 335995 Null 0.0385613993886001 -0.21042531
NSC 363787 Kaur-16-en-15-one,1,3,7,11-tetrakis(acetyloxy)-12-hydroxy-, (1.alpha.,3.beta.,7.beta.,11.beta.,12.alpha.)- 0.0385613993886001 -0.21462092
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.0385613993886001 -0.13217028
NSC 42972 Null 0.0385613993886001 -0.1508667
Total:85  Current:58    [First] [Prev] [Next] [Last]